|
thePharmacySPOTLIGHT
|
| August 4, 2017 |
|
| Osteoporosis Treatment Guidelines Released |
|
by Darrell Hulisz, RPh, PharmD
& Hannah Buehrle, Pharmacy Intern
|
| Osteoporosis is a common condition affecting almost 10 million people in the United States. As the bone ages, bone mass and strength decreases along with micro architectural deterioration. Untreated osteoporosis can increase the chances of getting a fracture. This disease affects… |
|
| Filling Opioid Prescriptions |
by Ken Baker, BS Pharm, JD
|
|
James T. was in an automobile accident in December. His injuries were extensive. His treatment was just as extensive and at times aggressive. There were two surgeries. James was in the hospital for 17 days in almost constant pain. He was finally released a little after New Year Day.1
James had lost his job about six months before the accident. His savings were exhausted and he had no insurance. He had no way of paying the hospital bill. While still in the hospital…
|
|
Shopko was founded by Pharmacist James Ruben in 1962. Serving over 300 communities in 21 states, we have remained true to his vision of being a mass retailer whose cornerstone is community health.
Exciting growth within Shopko means Pharmacist and Pharmacy Technician opportunities in many geographic areas within Shopko's retail and long-term care environments!
|
|
|
These hot jobs are provide by:
|
|
|
|
How often do you see denosumab prescribed to treat osteoporosis?
|
• Very often
• Occasionally
• Seldom
• Never
|
|
How likely would you be to recommend Qtern® in a patient already receiving dapagliflozin and saxagliptin with good blood glucose control?
|
Very likely - 8%
Somewhat likely - 8%
Neutral/no opinion yet - 24%
Somewhat unlikely - 12%
Very unlikely - 48%
|
|
|
|
Continuing Education for Pharmacy Professionals
|
|
Enroll now at www.rxschool.com for the latest online Live and Enduring Continuing Education.
|
|
|
|
|
|
|
|
Copyright © 2017 Pharmacy Choice - All rights reserved.
|
|
|
|
|
